EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Narrative Review and Perspective on Implementation Research on Intradermal Delivery Methods for Fractionated-Dose Inactivated Poliomyelitis Vaccine

Garba Bello Bakunawa, Mortada El-Shabrawi, Rana Muhammad Safdar, Asmatullah Arab, Catherine Daly, Paul LaBarre

Qeios · 30.04.2026 · 8 (4)

DOI: 10.32388/clbyi9.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Qeios, online erschienen am 30.04.2026. Verfasst von Garba Bello Bakunawa und 5 weiteren Autor:innen. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Recent trends in intradermal (ID) vaccination, as seen in the Global Polio Eradication Initiative and in the 2022 monkeypox (mpox) pandemic, are a reminder that vaccine administration to the dermis is a valuable alternative to the traditional routes of parenteral delivery. Despite favorable policy toward ID fractional inactivated polio vaccine (fIPV) in anticipation of oral polio vaccine (OPV) cessation, and despite WHO’s emergency-use authorization of fractional ID mpox vaccine in response to the 2024 mpox public health emergency of international concern, ID delivery remains an underutilized strategy with the potential for broader impact, including improved coverage and cost savings. We aim to provide a comprehensive narrative review and perspective on the published implementation research on novel ID delivery methods used for fIPV immunization to better understand the available ID delivery options, their implementation challenges, benefits, and opportunities for broader use for ID delivery of other vaccines, including rabies, malaria, and mpox. METHODS: This industry perspective summarizes selected published evidence. A literature search was conducted using PubMed [https://pubmed.ncbi.nlm.nih.gov/] to identify literature in any language, published between January 2015 and July 2024, with the terms “inactivated polio vaccine” and “intradermal delivery”. We identified studies that included implementation research on novel alternatives to needle and syringe (NS) ID delivery of fIPV. RESULTS: Of the 59 publications identified in the search, 14 met the exclusion and inclusion criteria as original studies on human subjects using novel delivery methods for ID administration of commercial fIPV vaccines. Six novel technologies were identified. In general, novel ID delivery technologies compared favorably against NS delivery. The benefits of several of these technologies include high acceptance among both healthcare workers and caregivers, improved coverage rates, and cost savings. Two alternative ID delivery technologies are commercially available. The needle-free technology, Tropis®-ID (PharmaJet), has the most extensive body of implementation research among the alternatives reviewed and is the only technology in this review to achieve WHO prequalification. CONCLUSION: Novel technologies for ID delivery of fIPV are viable and, in some cases, offer advantages over ID delivery with NS. Commercially available needle-free ID delivery has been thoroughly researched for campaign use and has been shown to reduce costs and increase coverage for polio immunization programs. ID delivery using novel alternatives to NS can be a valuable strategy for increasing equitable access to vaccines and for addressing vaccine shortages during campaigns and pandemic response. Commercially available needle-free ID delivery can increase campaign reach, enable effective strategies such as house-to-house campaigns, and potentially empower personnel without formal health training to administer vaccines. These results also suggest that alternative ID delivery methods should be evaluated in new vaccine development. This narrative review and perspective was sponsored by PharmaJet and reflects an industry frame of reference on intradermal delivery technologies for fIPV implementation.

Zitieren

APA

Bakunawa, G. B., El-Shabrawi, M., Safdar, R. M., Arab, A., Daly, C., & LaBarre, P. (2026). A Narrative Review and Perspective on Implementation Research on Intradermal Delivery Methods for Fractionated-Dose Inactivated Poliomyelitis Vaccine. Qeios, 8(4). https://doi.org/10.32388/clbyi9.3

Vancouver

Bakunawa GB, El-Shabrawi M, Safdar RM, Arab A, Daly C, LaBarre P. A Narrative Review and Perspective on Implementation Research on Intradermal Delivery Methods for Fractionated-Dose Inactivated Poliomyelitis Vaccine. Qeios. 2026;8(4). doi:10.32388/clbyi9.3

BibTeX
@article{Bakunawa2026,
  author = {Bakunawa, Garba Bello and El-Shabrawi, Mortada and Safdar, Rana Muhammad and Arab, Asmatullah and Daly, Catherine and LaBarre, Paul},
  title = {A Narrative Review and Perspective on Implementation Research on Intradermal Delivery Methods for Fractionated-Dose Inactivated Poliomyelitis Vaccine},
  journal = {Qeios},
  year = {2026},
  volume = {8},
  number = {4},
  doi = {10.32388/clbyi9.3}
}
Kostenlos starten →